Eagle's Eye View: Day 1 Highlights | ACC.19

In this special episode of Eagle's Eye View, Dr. Peter Block and Dr. Deepak Bhatt discuss highlights from Day 1 of ACC.19, including the Apple Heart Study, PIONEER-HF: Initiation of Angiotensin-Neprilysin Inhibition After Acute Decompensated HF, Hopeful Heart: Blended Collaborative Care For Treating HF and Comorbid Depression, and CODIACS-QoL: Depression Screening After ACS.

Subscribe on iTunes | Subscribe on Google Play

Clinical Topics: Anticoagulation Management, Arrhythmias and Clinical EP, Heart Failure and Cardiomyopathies, Prevention, Sports and Exercise Cardiology, Anticoagulation Management and Atrial Fibrillation, Implantable Devices, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Acute Heart Failure, Heart Failure and Cardiac Biomarkers

Keywords: ACC Annual Scientific Session, ACC19, EaglesEyeView, Depression, Quality of Life, Cost-Benefit Analysis, Depressive Disorder, Heart Failure, Secondary Prevention, Blood Pressure, Diuretics, Enalapril, Hyperkalemia, Hypotension, Natriuretic Peptide, Brain, Peptide Fragments, Neprilysin, Renin-Angiotensin System, Stroke Volume, Troponin T, Vasodilator Agents, Atrial Fibrillation, Arrhythmias, Cardiac, Sports

< Back to Listings